E-drug: Research on teaching critical appraisal of drug promotion
---------------------------------------------
Healthy Skepticism is moving into teaching and research.
The Jan/Feb 2002 edition of Healthy Skepticism International News presents
the backgrounder for a proposal to investigate teaching critical appraisal
of promotion to change attitudes towards drug promotion and thus improve
prescribing.
Contents:
1) A brief overview of the Australian general practice context. (The trends
are similar in many other countries.)
2) Risk factors for suboptimal prescribing
3) The analogy of cardiovascular disease as an aid to thinking about those
risk factors and the types of research that are needed.
4) Early results of some teaching of critical appraisal of promotion.
To read the edition visit
www.healthyskepticism.org and click on
"International Editions" then click on "Background for a research proposal".
One of the most popular sections of our website is our "Special Reports"
section.
www.healthyskepticism.org/special.htm
The following new reports have been added during March 2002:
Howard Brody A Matter Of Influence: Changing times call for changing
policies on the presence of drug company reps in residency programs. Health
Affairs March/April 2002
Frank Davidoff Between The Lines: Navigating The Uncharted Territory Of
Industry-Sponsored Research. Health Affairs March/April 2002
Paul Jung No Free Lunch: A young doctor's take on why residents' souls
should matter more than their stomachs. Health Affairs March/April 2002
Bert Spilker The Benefits And Risks Of A Pack Of M&Ms: A pharmaceutical
spokesman answers his industry's critics. Health Affairs March/April 2002
VANESSA O'CONNELL Ad Agencies Begin to Participate In Development of New
Drugs THE WALL STREET JOURNAL March 13, 2002
THOMAS M. BURTON Backlash Rises Against Flashy Ads For Prescription
Pharmaceuticals THE WALL STREET JOURNAL March 13, 2002
GARDINER HARRIS Drug Makers Offer Consumers Coupons for Free Prescriptions
THE WALL STREET JOURNAL March 13, 2002
de Laat E, Windmeijer F, Douven R. How does pharmaceutical marketing
influence doctors� prescribing behaviour? CPB Netherlands � Bureau for
Economic Policy Analysis The Hague, March 2002
Hannah Cleaver. Bribery of German Docs by Drug Companies Reuters Health Mar
11, 2002
Tim Craig Astroturf Lobbying: Community Leaders Decry Lobby Firm's Fax:
Apparent support of prescription plan really a move by foes Baltimore Sun
March 9, 2002
Mark Metherell. Patients face drug rations. Sydney Morning Herald 9 March
2002
MELODY PETERSEN TV Ads Spur a Rise in Prescription Drug Sales New York
Times March 8, 2002
Ray Moynihan. ACA urges cut to $4bn drug bill Australian Financial Review 08
Mar 2002 Page: 5
Italy suspends sales of sibutramine over adverse events Reuters Health
2002-03-07
Please note new contact details below.
regards,
Peter
Dr Peter R Mansfield
GP and consultant on marketing and appropriate therapeutics.
Visiting lecturer, Universities of Adelaide, Flinders, Queensland, South
Australia
Director, Healthy Skepticism
formerly MaLAM (Medical Lobby for Appropriate Marketing)
Defending health care from misleading and harmful marketing.
Advocacy, Research and Education.
www.healthyskepticism.org
34 Methodist St, Willunga SA 5172 Australia
ph/fax +61 8 8557 1040
peter@healthyskepticism.org
--
To send a message to E-Drug, write to: e-drug@usa.healthnet.org
To subscribe or unsubscribe, write to: majordomo@usa.healthnet.org
in the body of the message type: subscribe e-drug OR unsubscribe e-drug
To contact a person, send a message to: e-drug-help@usa.healthnet.org
Information and archives: http://www.healthnet.org/programs/edrug.html